Last reviewed · How we verify
NCT05836064
GastroBot: Artificial Intelligence Applied to Bowel Preparation
NA trial testing GastroBot in Colonic Polyp in 388 participants. Status unknown.
1 December 2024
Quick facts
| Lead sponsor | Institute of Gastroenterology and Advance Endoscopy |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 388 |
| Start date | 1 January 2024 |
| Primary completion | 1 December 2024 |
| Estimated completion | 28 April 2025 |
| Sites | 1 location across Argentina |
Drugs / interventions tested
- GastroBot
- Conventional explanation
Conditions studied
- Colonic Polyp — all drugs for Colonic Polyp →
- Colonic Neoplasms — all drugs for Colonic Neoplasms →
- Colonic Disease — all drugs for Colonic Disease →
- Colonic Adenoma — all drugs for Colonic Adenoma →
Sponsor
Institute of Gastroenterology and Advance Endoscopy
Who can join
Adults 18 to 80, any sex, with Colonic Polyp or Colonic Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is estimated that about 20% of colonoscopies have inadequate preparation. (5) This is associated with lengthy procedures and less detection of adenomas, reduces the screening intervals, and increases the costs and risks of complications. Several strategies have been proposed to improve the quality of bowel preparation. Mobile healthcare Apps have been developed to increase adherence to bowel preparation agents, improving the quality of bowel preparation. However, adherence to mobile healthcare Apps is also a quality criterion and a pending problem to solve with this new technology. GastroBot is a new technology based on artificial intelligence that allows, through a software bot, to carry out a personalized follow-up of the patient's bowel cleansing, advising the patient to overcome contingencies that arise with the preparation, which in other circumstances could lead to the failure of it. The primary aim of this study is to determine the improvement in bowel preparation after GastroBot assistance compared with the traditional explanation. As a secondary aim, this study also pursues to determine adenoma and polyp detection rates (ADR and PDR, respectively), bowel preparation agents' tolerance, and GastroBot functionality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05836064
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colonic Polyp
Currently open trials in the same condition.
- NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
- NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
- NCT06483503 — Extra Wide Field of View Lens Study · active not recruiting
- NCT06077435 — Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis · NA · recruiting
Other Institute of Gastroenterology and Advance Endoscopy trials
Trials by the same sponsor.
- NCT05422820 — The Argentina Brief Colonoscopy Difficulty Score (ABCD) · completed
- NCT04140435 — EUS-guided Through-the-needle Microforceps Biopsy Outcomes · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05836064 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Gastroenterology and Advance Endoscopy
- Last refreshed: 24 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05836064.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing